Boston Scientific Corporation
BSX
株式のランク
#409
この企業概要は英語でのみ提供されています。
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
株価
$41.88
最終同期: 2026-10-30
時価総額
$60.69B
変化（1日）
-1.89%
変化（1年）
-58.42%
国
US
株式データ: Financial Modeling Prep·更新日: ·投資助言ではありません·計算方法
取引 Boston Scientific Corporation (BSX)
カテゴリー
Healthcare
Boston Scientific Corporation（BSX）の営業利益率
November 2026 時点の営業利益率 TTM: 21.05%
Boston Scientific Corporation の最新の財務報告と株価によると、現在の営業利益率（TTM）は 21.05% です。2025 年末時点では 19.78% でした。
Boston Scientific Corporation の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 21.05% | 6.42% |
| 2025 | 19.78% | 25.75% |
| 2024 | 15.73% | 2.68% |
| 2023 | 15.32% | 6.54% |
| 2022 | 14.38% | -11.07% |
| 2021 | 16.17% | 166.83% |
| 2020 | 6.06% | -62.01% |
| 2019 | 15.95% | -9.79% |
| 2018 | 17.68% | 4.93% |
| 2017 | 16.85% | 14.31% |
| 2016 | 14.74% | 39.45% |
| 2015 | 10.57% | -7.69% |
| 2014 | 11.45% | -6.07% |
| 2013 | 12.19% | -11.09% |
| 2012 | 13.71% | -6.92% |
| 2011 | 14.73% | 7.13% |
| 2010 | 13.75% | -13.58% |
| 2009 | 15.91% | -1.12% |
| 2008 | 16.09% | 13.95% |
| 2007 | 14.12% | -10.58% |
| 2006 | 15.79% | -50.98% |
| 2005 | 32.21% | 2.29% |
| 2004 | 31.49% | 57.06% |
| 2003 | 20.05% | -4.07% |
| 2002 | 20.90% | 458.82% |
| 2001 | 3.74% | -85.24% |
| 2000 | 25.34% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 15.24% | -99.28% |
US
|
|
| 18.08% | -99.14% |
IE
|
|
| 21.25% | -98.99% |
US
|
|
| 14.84% | -99.30% |
DE
|
|
| 28.09% | -98.67% |
US
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。
Boston Scientific Corporationの営業利益率に関する質問
Boston Scientific Corporationの営業利益率はどのくらいですか？
2026年11月時点で、Boston Scientific Corporationの営業利益率は21.05%です。
Boston Scientific Corporationの2025年の営業利益率はどのくらいでしたか？
2025年のBoston Scientific Corporationの営業利益率は19.78%で、2024年は15.73%でした。
Boston Scientific Corporationの営業利益率は2020年以降どのように推移していますか？
2020年から2025年までのBoston Scientific Corporationの営業利益率は、2025年（19.78%）が最も高く、2020年（6.06%）が最も低くなっています。
Boston Scientific Corporationの営業利益率は類似企業と比べてどうですか？
Boston Scientific Corporationの営業利益率は21.05%で、上に挙げた類似企業5社のうち3社を上回っています。これらの企業の中で最も高いのはEdwards Lifesciences Corporationで、28.09%です。